Mariner’s Enfusion, Inc. ENFN Stock Holding History

Mariner’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,514	Closed	-$141K	–	3412
2024 Q2	$141K	Sell	16,514 -20,052	-55%	-$183K	﹤0.01%	2880
2024 Q1	$338K	Buy	+36,566	New	+$322K	﹤0.01%	2336

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

LECM

Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

NCM

Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mariner's ENFN Position: Q3 2024 in Review

Mariner sold out of Enfusion, Inc. (ENFN) in Q3 2024, closing a stake of 16,514 shares — an estimated $141K sold.

Mariner first reported a position in ENFN in Q1 2024 and held it in 2 quarters. The position peaked at $338K in Q1 2024. 109 funds tracked by Wall St. Rank hold ENFN as of Q3 2024.

Mariner reported no remaining Enfusion, Inc. position as of Q3 2024 after selling out during the quarter.
Mariner sold 16,514 Enfusion, Inc. shares in Q3 2024, an estimated $141K.
Mariner first reported a position in Enfusion, Inc. in Q1 2024 and held it in 2 quarters.
Mariner's Enfusion, Inc. position peaked at $338K in Q1 2024.
109 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q3 2024.

Based on Mariner's 13F filing for Q3 2024, filed 13 Nov 2024.